Brian Joseph OReilly
Known title: Head of InnovationsCIK: 0001965566
Associated companies
Transaction History
| GLRE | ▼ Sell | Open Market | 2,195 | $0 | 3/9/2026 | View on chart |
| GLRE | ▼ Sell | Open Market | 8,000 | $112K | 3/26/2025 | View on chart |
| GLRE | ▲ Buy | Grant | 6,112 | $0 | 3/14/2025 | View on chart |
| GLRE | ▲ Buy | Grant | 6,395 | $0 | 3/13/2025 | View on chart |
| GLRE | ▼ Sell | Open Market | 13,799 | $0 | 3/10/2025 | View on chart |
| GLRE | ▲ Buy | Grant | 18,342 | $0 | 3/15/2024 | View on chart |
| GLRE | ▲ Buy | Grant | 27,005 | $0 | 3/15/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Greenlight Capital Q2 Letter and Valuation Analysis
Greenlight Capital released its Q2 2026 letter, outlining recent performance and strategy. A SeekingAlpha piece notes the company’s book value is 0.7x, suggesting a low valuation until ROE is examined. These reports give a clearer view of the firm’s fundamentals and potential upside.
Greenlight Capital Q2 Letter and Valuation Analysis. Greenlight Capital released its Q2 2026 letter, outlining recent performance and strategy. A SeekingAlpha piece notes the company’s book value is 0.7x, suggesting a low valuation until ROE is examined. These reports give a clearer view of the firm’s fundamentals and potential upside.